Accessing Improved TB Medicines for Children
This report documents how the STEP-TB project has reshaped the market for pediatric TB drugs by reducing barriers to entry, engaging in innovative industry collaboration to launch optimized products, and mobilizing strong demand. This update is available in English, Spanish, French and Russian.
New Pathways for Childhood TB Treatment
This report documents how the STEP-TB project has reshaped the market for pediatric TB drugs by reducing barriers to entry, engaging in innovative industry collaboration to launch optimized products, and mobilizing strong demand.
MAP-IT: Model for Assessment of Pediatric Interventions for Tuberculosis
MAP-IT is an evidence-based framework that enables users to prioritize technology development options and to estimate the impact of those technologies on childhood tuberculosis.
International Journal of Tuberculosis and Lung Disease Childhood TB Issue (Supplement)
Collection of articles from leading voices and researchers in pediatric TB. Individual articles are available for view/download throughout this resource center.
About Childhood TB
MAP-IT: Model for Assessment of Pediatric Interventions for Tuberculosis
MAP-IT is an evidence-based framework that enables users to prioritize technology development options and to estimate the impact of those technologies on childhood tuberculosis.
See More Resources
- The global burden of tuberculosis mortality in children: a mathematical modelling study
- Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children
- Tuberculose de l’enfant: Feuille de route
- Lignes directrices concernant la prise en charge de la tuberculose chez l’enfant dans le cadre des programmes nationaux
- Roadmap for Childhood Tuberculosis
- Global burden of drug-resistant tuberculosis in children: a mathematical modelling study
- Childhood TB Learning Portal (IUATLD)
- Management of multidrug-resistant tuberculosis in children: A field guide (Second edition)
- International Journal of Tuberculosis and Lung Disease Childhood TB Issue (Supplement)
- Unmasking childhood tuberculosis in Pakistan: efforts to improve detection and management
- Treatment of childhood tuberculosis in India
- The journey to improve the prevention and management of childhood tuberculosis: the Kenyan experience
- Pediatric tuberculosis drug market: an insider perspective on challenges and solutions
- Counting children with tuberculosis: why numbers matter
- Childhood tuberculosis in the United States: shifting the focus to prevention
- About Childhood TB Infographic
- Childhood TB Activity Book
- Childhood TB – The Basics
- Childhood TB Education Tools for Children and Families
- NTP Management and Child TB
- Childhood TB Training Tool Kit
Child-Friendly TB Medicines
Accessing Improved TB Medicines for Children
This report documents how the STEP-TB project has reshaped the market for pediatric TB drugs by reducing barriers to entry, engaging in innovative industry collaboration to launch optimized products, and mobilizing strong demand. This update is available in English, Spanish, French and Russian.
See More Resources
- Scaling Life-Saving Interventions Faster | Case Studies Series
- New Pathways for Childhood TB Treatment
- Accessing Improved TB Medicines for Children (русский | Russian)
- Accessing Improved TB Medicines for Children (Español | Spanish)
- Accessing Improved TB Medicines for Children (Français | French)
- Nouvelles Formulations Pédiatriques à Doses Fixes pour Traiter la Tuberculose chez L’enfant
- Child-Friendly TB Medicines (Factsheet)
- New Fixed Dose Combinations for TB in Children (Factsheet)
- Proceedings: Global Consultation on Best Practices in the Delivery of Preventive Therapy for Households Exposed to Drug-Resistant Tuberculosis
- The procurement landscape of pediatric tuberculosis treatment: a Global Drug Facility perspective
- The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children
- From availability to uptake: planning for the introduction of new, child-friendly anti-tuberculosis formulations
- New Pediatric Treatments Infographic
- Policy Implementation Package for New TB Drug Introduction
- New Technologies for Tuberculosis Control
- Treatment of Childhood TB
R&D for Children
Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations
Article from The International Journal of Tuberculosis and Lung Disease
Advocates’ Corner
Key Populations Brief: Children
The Stop TB Partnership convened experts and representatives of vulnerable groups to develop this micro brief, which gives practical guidance on how to address the needs and views of children, who often have limited access to diagnosis, treatment, and care.
See More Resources
- Out of the shadows: shining a light on children with tuberculosis
- Abitter pill to swallow: the need for better medications for drugresistant tuberculosis in children
- Childhood tuberculosis: a unified response to a global problem
- Childhood TB Videos
- Call to Action: Bring Childhood TB out of the Shadows